Latest News about Commentary
Recent news which mentions Commentary
Activist Jana is back in the kitchen at Lamb Weston – Here’s what could happen next
November 02, 2024
From CNBC.com News
Insana: Musk, Paulson seek sharp U.S. budget cuts. This ‘shock therapy’ isn’t likely to work
October 30, 2024
From CNBC.com News
Vista's Robert Smith: How to prevent AI from further widening the racial wealth gap
October 29, 2024
From CNBC.com News
Top Wall Street analysts are upbeat on these dividend stocks
October 27, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
D.E. Shaw, Mantle Ridge zero in on key fixes to build shareholder value at Air Products
October 19, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
ValueAct takes a stake in Sanwa. How the activist can make a good company into a great one
September 28, 2024
From CNBC.com News
Op-ed: The UK's budget problems date back to the 2008 financial crisis
September 24, 2024
From CNBC.com News
Top Wall Street analysts find these stocks promising for the long haul
September 22, 2024
From CNBC.com News
Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors
September 17, 2024
From CNBC.com News
Top Wall Street analysts pick these dividend stocks for attractive returns
September 15, 2024
From CNBC.com News
Voss Capital wants to maximize shareholder value at International Money Express. How it may play out
September 14, 2024
From CNBC.com News
Top Wall Street analysts are bullish on the potential of these 3 stocks
September 08, 2024
From CNBC.com News
Activist Ancora joins investors’ calls for a strategic review at Forward Air. Here’s what may happen next
September 07, 2024
From CNBC.com News
Top Wall Street analysts are bullish on these 3 dividend-paying stocks
September 01, 2024
From CNBC.com News
From CNBC.com News
Op-ed: The case for a 40-year mortgage
August 20, 2024
From CNBC.com News
From CNBC.com News
Top Wall Street analysts are bullish on these dividend stocks
August 11, 2024
From CNBC.com News
Activist Oasis suggests three steps to build shareholder value at embattled Kobayashi Pharmaceutical
August 10, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.